The male-specific factor Sry harbors an oncogenic function

Oncogene

Volumn 33, Issue 23, 2014, Pages 2978-2986

  Murakami, S ^a   Chishima, S ^a   Uemoto, H ^a   Sakamoto, E ^a   Sato, T ^a   Kurabe, N ^a   Kawasaki, Y ^a   Shibata, T ^b   Akiyama, H ^a   Tashiro, F ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

c Myc; hepatocarcinogenesis; SGF29; SRY; STAGA complex

Indexed keywords

BINDING PROTEIN; HIGH MOBILITY GROUP PROTEIN; SGF29 PROTEIN; TESTIS DETERMINING FACTOR; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CARCINOGENICITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE SILENCING; HEPATOCELLULAR CARCINOMA CELL LINE; LUCIFERASE ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FUNCTION; TUMOR INVASION; UPREGULATION;

RODENTIA;

ACETYLTRANSFERASES; ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HISTONE ACETYLTRANSFERASES; HMG-BOX DOMAINS; MALE; MICE; MICE, SCID; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; RATS; SEX-DETERMINING REGION Y PROTEIN;

EID: 84902170540     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.262     Document Type: Article

References (36)

1. Kaposi- Noval P, Libbrecht L, Woo H, Lee Y-H, Sears NC, Conner EA et al. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis. Cancer Res 2009; 69: 2775-2782.
2. Amati B, Frank SR, Donjerkovic D, Taubert S. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim Biophys Acta 2001; 1471: M135-M145. (Pubitemid 32206689)
3. Lüscher B. Function and regulation of the transcription factors of the Myc/Max/ Mad network. Gene 2001; 277: 1-14. (Pubitemid 32972106)
4. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. The novel ATMrelated protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 1998; 94: 363-374. (Pubitemid 28376080)
5. McMahon SB, Wood MA, Cole MD. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol Cell Biol 2000; 20: 556-562. (Pubitemid 30023097)
6. Park J, Kunjibettu S, McMahon SB, Cole MD. The ATM-related domain of TRRAP is required for histone acetyltransferase recruitment and Myc-dependent oncogenesis. Genes Dev 2001; 15: 1619-1624. (Pubitemid 32702583)
7. Lee KK, Workman JL. Histone acetyltransferase complexes: one size doesnt fit all. Nat Rev Mol Cell Biol 2007; 8: 284-295. (Pubitemid 46474661)
8. Vermeulen M, Eberl HC, Matarese F, Marks H, Denissov S, Butter F et al. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers. Cell 2010; 142: 967-980.
9. Bian C, Xu C, Ruan J, Lee KK, Burke TL, Tempel W et al. Sgf29 binds histone H3K4me2/3 and is required for SAGA complex recruitment and histone H3 acetylation. EMBO J 2011; 30: 2829-2842.
10. Kurabe N, Katagiri K, Komiya Y, Ito R, Sugiyama A, Kawasaki Y et al. Deregulated expression of a novel component of TFTC/STAGA histone acetyltransferase complexes, rat SGF29, in hepatocellular carcinoma: possible implication for the oncogenic potential of c-Myc. Oncogene 2007; 26: 5626-5634. (Pubitemid 47267841)
11. Lefebvre V, Dumitriu B, Penzo-Mendez A, Han Y, Pallavi B. Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. Int J Biochem Cell Biol 2007; 39: 2195-2214. (Pubitemid 47484275)
12. Phillips NB, Jancso-Radek A, Ittah V, Singh R, Chan G, Haas E et al. SRY and human sex determination: the basic tail of the HMG box functions as a kinetic clamp to augment DNA bending. J Mol Biol 2006; 358: 172-192.
13. Nishino K, Hattori N, Tanaka S, Shiota K. DNA methylation-mediated control of Sry gene expression in mouse gonadal development. J Biol Chem 2004; 279: 22306-22313. (Pubitemid 38679427)
14. Albrecht KH, Eicher EM. Evidence that Sry is expressed in pre-Sertoli cells and Sertoli and granulosa cells have a common precursor. Dev Biol 2001; 240: 92-107. (Pubitemid 33141111)
15. Bullejos M, Koopman P. Spatially dynamic expression of Sry in mouse genital ridges. Dev Dyn 2001; 221: 201-205. (Pubitemid 32476568)
16. Sekido R, Lovell-Badge R. Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer. Nature 2008; 453: 930-934. (Pubitemid 351832560)
17. Sugiyama A, Miyagi Y, Komiya Y, Kurabe N, Kitanaka C, Kato N et al. Forced expression of antisense 14-3-3 beta RNA suppresses tumor growth in vivo and vivo. Carcinogenesis 2003; 24: 1549-1559. (Pubitemid 37160846)
18. Komiya Y, Kurabe N, Katagiri K, Ogawa M, Sugiyama A, Kawasaki Y et al. A novel binding factor of 14-3-3beta functions as a transcriptional repressor and promotes anchorage-independent growth, tumorigenicity, and metastasis. J Biol Chem 2008; 283: 18753-18764.
19. Mattheews V, Tanaka K, Driacoll J, Ichikawa A, Goldberg A. Involvement of the proteasome in various degaradation processes in mammalian cells. Proc Nat Acad Sci USA 1989; 86: 2597-2601. (Pubitemid 19112594)
20. Kawasaki Y, Adachi N, Yamazaki T, Todoroki R, Gotou Y, Komiya Y et al. Cancer stem cells in aflatoxin B1-induced rat hepatocellular carcinoma K2 cells. Mycotoxins 2007; 57: 87-93.
21. Murray JD, Braithwaite AW, Taylor IW, Bellett AJD. Adenovirus-induced alteration of the cell growth cycle: effects of mutation in early regions E1A and E2B. J Virol 1982; 44: 1072-1075. (Pubitemid 13250573)
22. Katoh H, Ojima H, Saito S, Kondo T, Hosoda F, Imoto I et al. Genetically distinct and clinically relevant classification of hepatocellular carcinoma: putative therapeutic targets. Gastroenterology 2007; 133: 1475-1486. (Pubitemid 350029748)
23. Iyengar RV, Pawlik CA, Krull EJ, Phelps DA, Burger RA, Harris LC et al. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYCregulated protein expression. Cancer Res 2001; 61: 3045-3052. (Pubitemid 32691953)
24. Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA et al. Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation. Cancer Cell 2005; 7: 433-444. (Pubitemid 40719127)
25. Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A et al. Metastasis-Associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proc Natl Acad Sci USA 2005; 102: 13968-13973. (Pubitemid 41377687)
26. Palaskas N, Larson SM, Schultz N, Komisopoulou E, Wong J et al. 18F-Fluorodeoxyglucose positron emission tomography marks Myc-overexpressing human basal-like breast cancers. Cancer Res 2011; 71: 5164-5174.
27. Liu L, Ulbrich J, Wüstefeld T, Aeberhard L, Kress TR, Muthalagu N et al. Deregulated MYC expression induces dependence upon AMPK-related kinase 5. Nature 2012; 483: 608-612.
28. Bradford ST, Wilhelm D, Bandiera R, Vidal V, Schedl A, Koopman P. A cell-Autonomous role for WT1 in regulating Sry in vivo. Hum Mol Genet 2009; 18: 3429-3438.
29. Ling S, Chang X, Schultz L, Lee TK, Chaux A, Marchionni L et al. An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. Cancer Res 2011; 71: 3812-3821.
30. Thomsen MK, Ambroisine L, Wynn S, Cheah KS, Foster CS et al. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res 2010; 70: 979-987.
31. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med 2011; 17: 313-319.
32. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648. (Pubitemid 24067706)
33. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111. (Pubitemid 33041634)
34. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial- mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715. (Pubitemid 351636299)
35. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, Dirks PB. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009; 8: 806-823.
36. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676. (Pubitemid 44233629)